Heron Therapeutics (HRTX) EBITDA Margin Growth (3y) (2020 - 2026)
Heron Therapeutics (HRTX) EBITDA Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
8,716.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
8,716.00 |
| Dec 31, 2025 |
5,877.00 |
| Sep 30, 2025 |
11,220.00 |
| Jun 30, 2025 |
19,758.00 |
| Mar 31, 2025 |
27,911.00 |
| Dec 31, 2024 |
27,349.00 |
| Sep 30, 2024 |
21,117.00 |
| Jun 30, 2024 |
24,658.00 |
| Mar 31, 2024 |
25,434.00 |
| Dec 31, 2023 |
27,235.00 |
| Sep 30, 2023 |
21,366.00 |
| Jun 30, 2023 |
10,958.00 |
| Mar 31, 2023 |
9,006.00 |
| Dec 31, 2022 |
9,910.00 |
| Sep 30, 2022 |
-7,905.00 |
| Jun 30, 2022 |
-6,730.00 |
| Mar 31, 2022 |
-7,337.00 |
| Dec 31, 2021 |
-9,260.00 |
| Sep 30, 2021 |
-3,191.00 |
| Jun 30, 2021 |
-4,850.00 |
